The future of UK gene therapy innovation
The network of Innovation Hubs for Gene Therapies is a new UK initiative designed to advance the clinical development of new genetic treatments through the production of GMP (Good Manufacturing Practice) viral vectors, alongside translational support and regulatory advice.
Three new dedicated facilities have been created at King's College London, NHS Blood and Transplant in Bristol, and the University of Sheffield.
LATEST NEWS
For Researchers
We can help to fund, develop and protect your academic research:
-
Capabilities: The Hubs can manufacture AAV and LV vectors up to 50L capacity. Find out more about the Hub’s manufacturing capabilities.
-
Funding applications: The network is able to provide support for grant funding applications, through the confirmation of pricing and timelines for manufacture. Get in touch with us.
For Industry
We can work with you to develop potential projects:
-
Partnerships: The Innovation Hubs are keen to discuss possible partnering opportunities with companies working in the gene therapies sector. Please contact us if you are interested.
Access Our Facilities
The Innovation Hubs are seeking gene therapy research projects to support through GMP viral vector manufacture. Please get in touch if you are interested in using our facilities in the future.
